Merck & Co. Inc. buy melinda
Start price
20.10.17
/
50%
€57.58
Target price
20.04.18
€59.53
Performance (%)
-6.62%
End price
20.04.18
€52.90
Summary
This prediction ended on 20.04.18 with a price of €52.90. With a performance of -6.62%, the BUY prediction for Merck & Co. Inc. by melinda closed slightly in the red. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Merck & Co. Inc. | 12.179% | 12.179% | 14.874% | 5.241% |
| iShares Core DAX® | -1.020% | 0.271% | 13.941% | 56.827% |
| iShares Nasdaq 100 | -3.122% | -1.929% | 1.920% | 83.028% |
| iShares Nikkei 225® | 0.649% | 6.582% | 21.176% | 50.695% |
| iShares S&P 500 | -0.142% | -0.295% | 1.363% | 57.560% |
According to melinda what are the pros and cons of Merck & Co. Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Merck & Co. Inc. diskutieren
PHARMA
Merck and Company spezialisiert auf die Entwicklung unter Rezept verkauft, Herstellung und Vermarktung von therapeutischen Produkten und Impfstoffen. Der Umsatz ist Aktivität gliedern sich wie folgt: - Verkauf von pharmazeutischen Erzeugnissen (73,8%): für die Behandlung von Bluthochdruck
LYNPARZA hat das Potenzial , eine neue Behandlungsoption für Patienten mit metastasierendem HER2-negativen metastasierendem Brustkrebs bieten
(Laufzeit überschritten)
Stopped prediction by melinda for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.76
26.10.21
26.10.21
€65.00
26.10.22
26.10.22
38.64%
27.10.22
27.10.22
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€71.50
01.03.19
01.03.19
€77.00
04.11.21
04.11.21
-1.04%
26.10.21
26.10.21
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€63.84
20.10.17
20.10.17
€66.00
20.04.18
20.04.18
-6.62%
20.04.18
20.04.18
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€56.64
21.07.17
21.07.17
€59.53
14.09.17
14.09.17
5.90%
14.09.17
14.09.17
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€62.79
21.07.17
21.07.17
€66.00
14.09.17
14.09.17
5.90%
14.09.17
14.09.17
Could be worthwhile Investment >10% per year